Pfizer Arthritis Drug Quenched Pain Too Well, Leading to Damage

An experimental arthritis drug from Pfizer Inc. reduced pain more than researchers anticipated, doctors said. It also allowed previously hobbled patients to overuse and permanently damage their joints.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.